Dr Reddys Laboratories (RDY) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Sep 30, 2026: 0 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about RDY filings

Are insiders buying or selling Dr. Reddy’s Laboratories Ltd ADR (RDY) stock?

Neither. Dr. Reddy’s Laboratories Ltd ADR (RDY) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded RDY recently?

None. No member of Congress disclosed a RDY trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this RDY smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

MWMarshall WaceQ3 2026 13FTrimmed$26M

13F: filed up to 45 days late.

Smart money on RDY

Lean short1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Congress
No recent politician filings found
Funds
- Marshall Wace, trimmed -$26M, holdings at Sep 30
Lean short · thin0 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about RDY filings

Are insiders buying or selling Dr. Reddy’s Laboratories Ltd ADR (RDY) stock?

Neither. Dr. Reddy’s Laboratories Ltd ADR (RDY) insiders filed no open-market purchases or sales in the 90 days to Nov 14, 2026, according to SEC Form 4 filings.

Which members of Congress have traded RDY recently?

None. No member of Congress disclosed a RDY trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this RDY smart-money data?

Funds

What funds are doing

1 move · 6 mo

Sells/Trims$26.0M

Sells/Trims (1)

MW
Marshall Wace
Q3 2026 13F
$26.0M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Oct 23, 2026

Earnings came in 25.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Oct 23, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.12-25.00% miss

$0.16 expected

Revenue

INR 86.71B

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Oct 23, 2026	$0.12est. $0.16	-25.00%miss	INR 86.71BSEC filing	-1.5%from INR 88.05B
Jun 30, 2026Reported Jul 21, 2026	$0.06est. $0.17	-64.71%miss	INR 80.70BSEC filing	-5.6%from INR 85.45B
Mar 31, 2026Reported May 11, 2026	$0.03est. $0.16	-82.18%miss	INR 75.16BSEC filing	No year-ago quarter
Dec 31, 2025Reported Jan 20, 2026	$0.16est. $0.16	+1.94%beat	Not on file	Not on file
Sep 30, 2025Reported Oct 24, 2025	$0.20est. $18.31	-98.92%miss	INR 88.05BSEC filing	No year-ago quarter
Jun 30, 2025Reported Jul 23, 2025	$17.02est. $0.21	+$16.81beat	INR 85.45BSEC filing	No year-ago quarter
Mar 31, 2025Reported May 9, 2025	$19.11est. $17.13	+11.56%beat	INR 325.54B · FYSEC filing	No year-ago quarter
Dec 31, 2024Reported Jan 29, 2025	$16.94est. $16.15	+4.89%beat	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $14.85
High: $14.94
Low: $14.73
Prev close: $14.84
52-wk high: $15.49
52-wk low: $11.28
Mkt cap: $12.31B
P/E: 41.0x
ROE: +7.3%
Fwd P/E: 31.6x
Beta: 0.20
Div yield: 0.57%
P/S: 0.0x
P/B: 3.0x
Profit margin: +8.5%
Op margin: +9.1%

Fundamentals

Is the business strong?

Richly priced and running thin margins.

Net margin: 8.5%
P/E: 41.03
Forward P/E: 31.65
Market cap: $12.3B

Valuation

P/S0.04
P/B2.99
Dividend yield0.6%

Quality

Operating margin9.1%
ROE7.3%
ROA3.4%

Growth

Beta0.20

Technicals

Price structure

This stock is in a strong uptrend, and looks overbought after a fast run-up.

Trend

Strong uptrend

85 / 100

RSI 14

77overbought

20D volatility

24%annualized

52-week range

$14.73

$11.28$15.49

20D support

$12.94recent floor

20D resistance

$15.08recent ceiling

Returns

5D +1.4%20D +14.2%60D +21.6%

Price vs moving averages

SMA20 +4.8%SMA50 +13.4%SMA200 +11.5%

Volume pace

0.92xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Oct 23, 2026

$0.12est. $0.16

-25.00%

INR 86.71BSEC filing

-1.5%from INR 88.05B

Jun 30, 2026Jul 21, 2026

$0.06est. $0.17

-64.71%

INR 80.70BSEC filing

-5.6%from INR 85.45B

Mar 31, 2026May 11, 2026

$0.03est. $0.16

-82.18%

INR 75.16BSEC filing

No year-ago quarter

Dec 31, 2025Jan 20, 2026

$0.16est. $0.16

+1.94%

Not on file

Sep 30, 2025Oct 24, 2025

$0.20est. $18.31

-98.92%

INR 88.05BSEC filing

No year-ago quarter

Jun 30, 2025Jul 23, 2025

$17.02est. $0.21

+$16.81

INR 85.45BSEC filing

No year-ago quarter

Mar 31, 2025May 9, 2025

$19.11est. $17.13

+11.56%

INR 325.54B · FYSEC filing

No year-ago quarter

Dec 31, 2024Jan 29, 2025

$16.94est. $16.15

+4.89%

Not on file

Dr. Reddy’s Laboratories Ltd ADR

Smart money at a glance

What do analysts expect?

Questions about RDY filings

Smart money on RDY

Questions about RDY filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 25.0% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Dr. Reddy’s Laboratories Ltd ADR

Smart money at a glance

What do analysts expect?

Questions about RDY filings

Smart money on RDY

Questions about RDY filings

What funds are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 25.0% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Dr. Reddy’s Laboratories Ltd ADR

Overview

Questions about RDY filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Dr. Reddy’s Laboratories Ltd ADR

Overview

Questions about RDY filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.